Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
35,742,013
-
Share change
-
-132,192
-
Total reported value
-
$1,173,028,889
-
Put/Call ratio
-
60%
-
Price per share
-
$32.84
-
Number of holders
-
204
-
Value change
-
-$3,279,137
-
Number of buys
-
103
-
Number of sells
-
94
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q4 2016
As of 31 Dec 2016,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
204 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,742,013 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Fund Advisors, DIMENSIONAL FUND ADVISORS LP, GLENMEDE TRUST CO NA, ACADIAN ASSET MANAGEMENT LLC, ABERDEEN ASSET MANAGEMENT PLC/UK, STATE STREET CORP, SNYDER CAPITAL MANAGEMENT L P, RENAISSANCE TECHNOLOGIES LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
204
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.